Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Galderma Enters Nutraceuticals Market - Happi
Company News

Galderma Enters Nutraceuticals Market

Galderma is entering the nutraceutical market through the acquisition of certain assets of Inneov Group, including Nutri-Care D, Duocap, Densilogy, Densilogy Men, Fermete, Fermete Aox, Firmness, Pre-Hyaluron 465, Solar and Sun Sensitivity products.

“The nutraceutical category has a strong fit with our self-medication business. Many of the Innéov brands are complementary to our existing portfolio of skin health medical solutions,” said Stuart Raetzman, CEO of Galderma. “We look forward to expanding our range of nutraceutical products and to serving consumers’ needs around the world.”

“Partnering with healthcare professionals to meet the needs of dermatology patients is Galderma’s unique focus,” added Janusz Czernielewski, CMO of Galderma. “Backed by science and clinical evidence and recommended by healthcare professionals, the nutraceutical products can play an important role in the health of skin, hair and nails throughout the course of people’s lives.”

On April 24 Nestlé Skin Health announced that Galderma, its company focused on medical solutions, had entered into an agreement under which it will acquire certain assets of Innéov Group, contingent upon competition authority clearance.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters